KRX New Deal Index Rebalance Preview: Some Big Impact Names
There are some high impact changes expected at the March rebalance of the New Deal indices mainly from changes to the top 3 stocks in the Battery...
Introducing KODEX Top 5 Plus ETF Rebalancing Event
KODEX Top 5 Plus ETF rebalancing will likely feature one constituent change, which can deliver a juicy day trading return.
Wuxi Biologics Placement - Lesser Discount than Recent Deals but Still Looks Good
Wuxi Biologics Holdings is looking to raise up to US$513m by selling about 1.3% of Wuxi Biologics (2269 HK). This is the company's 16th placement...
Samsung Biologics (207940 KS): Near-Term Key Positive Catalysts
Upcoming participation in healthcare conference, Q4 result, and biosimilar launch in US are key catalysts to watch. Ongoing capex amid strong order...
Smartkarma Originals